ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery using Recombinant Human Hyaluronidase PH20 (Original PDF from Publisher)

By David W. Kang, Renee Tannenbaum
‘ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20’ provides readers with in-depth information on the potential benefits and challenges of subcutaneous (SC) drug delivery, the biology of hyaluronan and hyaluronidases in the SC space, and a comprehensive overview on the history of hyaluronidases and the development of recombinant human hyaluronidase PH20 (rHuPH20). Current applications of rHuPH20 as well as approved biotherapeutics utilizing HuPH20-facilitated SC drug delivery are summarized, and the underlying non-clinical and clinical development approaches are introduced as a basis for future application to biologics in various disease areas.

Product Details

• ASIN ‏ : ‎ B0B57JMGDJ
• Publisher ‏ : ‎ S. Karger; 1st edition (June 14, 2022)
• Publication date ‏ : ‎ June 14, 2022
• Language ‏ : ‎ English
• Screen Reader ‏ : ‎ Supported
• Page numbers source ISBN ‏ : ‎ 3318070769